Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 17

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 17
---
</div>

An increase in market interest rates may have an adverse effect on the market price of and our ability to pay distributions on our Series B Preferred Stock.

One of the factors that investors may consider
in deciding whether to buy or sell our Series B Preferred Stock is the dividend rate as a percentage of the stock price, relative
to market interest rates. If market interest rates increase, prospective investors may seek alternative investments paying higher dividends
or interest. As a result, interest rate fluctuations and capital market conditions can affect the market price of our Series B Preferred
Stock. For instance, if interest rates rise, the market price of our Series B Preferred Stock could decrease because potential investors
may require a higher dividend yield as market rates on our interest-bearing instruments such as bonds rise. In addition, to the extent
we have variable rate debt, rising interest rates would result in increased interest expense on variable rate debt, thereby adversely
affecting our cash flow and our ability to service our indebtedness and pay distributions on our Series B Preferred Stock.

If you own shares of our Series B Preferred Stock, you will not be entitled to any rights with respect to our common stock, but you will be subject to all changes made with respect to our common stock.

If you own shares of our Series B Preferred
Stock, you will not be entitled to any rights with respect to our common stock (including, without limitation, voting rights and rights
to receive any dividends or other distributions on our common stock), but you will be subject to all changes affecting the common stock.

You will have rights with respect to our common
stock only if and when we deliver common stock to you upon conversion of your shares of Series B Preferred Stock in connection with
a Change of Control, and, in certain cases, under the conversion rate adjustments applicable to our Series B Preferred Stock. For
example, in the event that an amendment is proposed to our charter requiring stockholder approval and the record date for determining
the stockholders of record entitled to vote on the amendment occurs prior to the delivery of common stock to you following a conversion,
you will not be entitled to vote on the amendment, although you will nevertheless be subject to any changes in the powers, preferences
or special rights of our common stock.

Holders of Series B Preferred Stock will have limited voting rights.

Holders of the Series B Preferred Stock have
no voting rights with respect to matters that generally require the approval of voting stockholders. However, holders of the Series B
Preferred Stock will have the